Complimentary Gartner® Report
Hype Cycle™ for U.S. Healthcare Payers, 2022

August 2022
The sought-after Gartner® Hype Cycle™ for U.S. Healthcare Payers, 2022 is now available. U.S healthcare payer CIO's should use this to plan new and manage existing investments for business optimization and transformation.
As per Gartner® “A key theme this year is the composable enterprise architecture, which will enable CIOs to flexibly reconfigure IT applications and meet new business requirements on demand…Interoperable data exchange across the healthcare continuum has never been more possible.”
Get the insights you need quickly by referencing the priority matrix to help inform your organization's technology priorities.
Read the report today to learn:
- How much value your organization could expect to realize from the effective implementation of your technology investments
- When the technology will be mature enough to help deliver on the promise of that value
Smile Digital Health's data fabric solutions help healthcare and life science organizations overcome obstacles and drive the digital transformation that enables innovation and creates new value.

Gartner, Hype Cycle for U.S. Healthcare Payers, 2022, Mandi Bishop, Connie Salgy, 15 July 2022
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Smile CDR.
Gartner and Hype Cycle are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.